DWTX
Dogwood Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$52.80M
P/E Ratio
1.34
EPS
$1.17
Beta
1.71
52W High
$9.50
52W Low
$1.28
50-Day MA
$1.68
200-Day MA
$3.85
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company is headquartered in Alpharetta, Georgia.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-28.61M |
| Operating Margin | 0.00% |
| Return on Equity | -49.20% |
| Return on Assets | -19.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.52 |
| Price-to-Book | 0.66 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.22 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $33.63M |
| Float | $5.07M |
| % Insiders | 74.49% |
| % Institutions | 10.97% |
Historical Volatility
HV 10-Day
75.03%
HV 20-Day
72.26%
HV 30-Day
84.34%
HV 60-Day
94.70%
HV Rank
49.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.00 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026